CLOSE X

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE2597.158.8 (+0.34 %)
PREV CLOSE ( ) 2588.35
OPEN PRICE ( ) 2590.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3820
TODAY'S LOW / HIGH ( )2558.30 2605.45
52 WK LOW / HIGH ( )2022.05 3485.75
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (West),
Mumbai,
Maharashtra-400067

Phone 022-66061000

Email legal.info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
12May Ajanta Pharma informs about annual sec
Ajanta Pharma has informed that it enclosed the copy of the Annual Secre..
05May Ajanta Pharma informs about written tr
Further to communication dated 30th April 2025 on earnings call, pursuan..
02May Ajanta Pharma informs about newspaper
Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has..
21Mar Ajanta Pharma to expand manufacturing
Ajanta Pharma is expanding its manufacturing capabilities by adding a st..
20Mar Ajanta Pharma informs about updates
Ajanta Pharma has informed that the Company is expanding its manufacturi..
Financials
Rs. in Millions
QTR Mar 25 ANNUAL 25
Net Profit1934.39168.9
Gross Profit 2281.5 11800.6
Operating Profit 2675.813245.9
Net Sales 10139.443220.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 6314.35 (4.50%)
M.Cap ( in Cr)14542.34
Alkem Laboratories (BSE)
 5290.35 (3.18%)
M.Cap ( in Cr)63254.07
NGL Fine-Chem (BSE)
 1207.50 (5.00%)
M.Cap ( in Cr)746.00
Pfizer (BSE)
 4456.25 (1.26%)
M.Cap ( in Cr)20386.33
Akums Drugs & Pharma (BSE)
 560.60 (8.07%)
M.Cap ( in Cr)8823.51
Shareholding Pattern
PROMOTERS 66.26%
MUTUAL FUNDS/UTI 15.13%
NON-INSTITUTION 7.39%
FI/BANKS/INSURANCE 1.58%
GOVERNMENT 0.01%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data April 2025 Broking Complaints Data April 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.